Literature DB >> 22183776

Intravenous thrombolysis for acute cerebral ischaemia in old stroke patients ≥ 80 years of age.

Gregoire Boulouis1, Frederic Dumont, Charlotte Cordonnier, Marie Bodenant, Didier Leys, Hilde Hénon.   

Abstract

Despite increasing life expectancy, few data exist on the outcome of elderly stroke patients treated with IV thrombolysis. We analyzed the prospectively collected data from the Lille University Hospital stroke unit on patients treated with IV rt-PA within 4.5 h, comparing patients ≥80 years to younger ones. We considered the following outcomes: neurological improvement at the acute phase (NIHSS 0 or 1 at 24 h, or if the difference between NIHSS at 24 h and at baseline was ≥4), occurrence of intracerebral haemorrhage, mortality and functional outcome in survivors (favourable if mRS ≤2 or equal to pre-stroke score) at 3 months. Predictors of vital and functional outcome were determined using logistic regression analysis. Four hundred patients were treated with IV rt-PA, 98 (25%) being ≥80 years. The proportion of patients with neurological improvement at the acute phase (31 vs. 40%, OR 0.7, 95%CI 0.4-1.2), and with ICH (19 vs. 21%, OR 0.9, 95%CI 0.5-1.7) was similar among older and younger patients. At 3 months, 35% of patients ≥80 years had died; 52% of survivors had favourable functional outcome. Using multivariate analysis, age ≥80 years was an independent predictor of death (3.4; 95%CI 1.6-7.3), and of reduced likelihood of favourable functional outcome in survivors (OR 0.3; 95%CI 0.2-0.7) at 3 months. Although outcome at 3 months is worse for older patients than for their younger counterparts, our results are encouraging with a similar proportion of patients with early neurological improvement and with ICH in old and young patients and about half of the survivors having a favourable functional outcome in patients ≥80 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183776     DOI: 10.1007/s00415-011-6359-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

Review 2.  Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review.

Authors:  Elena Meseguer; Julien Labreuche; Jeam Marc Olivot; Halim Abboud; Philippa C Lavallee; Olivier Simon; Lucie Cabrejo; Amaya Echeverria; Isabelle F Klein; Mikael Mazighi; Pierre Amarenco
Journal:  Age Ageing       Date:  2007-12-03       Impact factor: 10.668

3.  Intravenous tissue plasminogen activator and stroke in the elderly.

Authors:  W T Longstreth; Ronit Katz; David L Tirschwell; Mary Cushman; Bruce M Psaty
Journal:  Am J Emerg Med       Date:  2010-03       Impact factor: 2.469

4.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

5.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

6.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

7.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

8.  The response to IV rt-PA in very old stroke patients.

Authors:  M Gómez-Choco; V Obach; X Urra; S Amaro; A Cervera; M Vargas; A Chamorro
Journal:  Eur J Neurol       Date:  2008-01-09       Impact factor: 6.089

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive.

Authors:  Nishant K Mishra; Niaz Ahmed; Grethe Andersen; José A Egido; Perttu J Lindsberg; Peter A Ringleb; Nils G Wahlgren; Kennedy R Lees
Journal:  BMJ       Date:  2010-11-23
View more
  8 in total

1.  Influence of neurologists' experience on the outcome of patients treated by intravenous thrombolysis for cerebral ischaemia.

Authors:  Amélie Tuffal; Solène Moulin; Nelly Dequatre-Ponchelle; Marie Bodenant; Frédéric Dumont; Catherine Lefebvre; Hilde Hénon; Stéphanie Debette; Charlotte Cordonnier; Didier Leys
Journal:  J Neurol       Date:  2015-03-06       Impact factor: 4.849

Review 2.  Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.

Authors:  Hakan Sarikaya
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

3.  Quality of Life After Off-Label Thrombolysis for Ischemic Stroke in Elderly Patients.

Authors:  Capucine Diard-Detoeuf; Séverine Debiais; Mélanie Imbert; Alexandra Musikas; Marie Gaudron; Emeline Laurent; Bertrand De Toffol; Caroline Hommet; Karl Mondon
Journal:  Drugs Aging       Date:  2015-11       Impact factor: 3.923

Review 4.  Evolving prehospital, emergency department, and "inpatient" management models for geriatric emergencies.

Authors:  Christopher R Carpenter; Timothy F Platts-Mills
Journal:  Clin Geriatr Med       Date:  2013-02       Impact factor: 3.076

5.  Stroke. Support for IV tPA in ischaemic stroke in elderly people.

Authors:  Susan W Law; Steven R Levine
Journal:  Nat Rev Neurol       Date:  2015-12-16       Impact factor: 42.937

Review 6.  Effectiveness of alteplase in the very elderly after acute ischemic stroke.

Authors:  Josef Yayan
Journal:  Clin Interv Aging       Date:  2013-07-24       Impact factor: 4.458

7.  Practice Patterns and Barriers for Intravenous Thrombolysis: A Survey of Neurologists in Saudi Arabia.

Authors:  Mohammed H Alanazy; Rima B Barakeh; Alanood Asiri; Maha F Edrees; Ahmad R Abuzinadah; Bandar N Aljafen; Taim Muayqil
Journal:  Neurol Res Int       Date:  2018-02-13

8.  The impact of intravenous thrombolysis on outcome of patients with acute ischemic stroke after 90 years old.

Authors:  S Sagnier; P Galli; M Poli; S Debruxelles; P Renou; S Olindo; F Rouanet; I Sibon
Journal:  BMC Geriatr       Date:  2016-08-25       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.